Tectonic Therapeutic, Inc.TECXNASDAQ

Loading chart...

Want to monitor TECX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

Disney Reports Solid Quarterly Earnings, Discloses $110M Hit From YouTube TV Carriage Fight

New Strong Sell Stocks for February 2nd

Oil News: Crude Oil Futures Plunge as Iran Talks Ease Supply Disruption Fears

MAGY Only Makes Sense If You Already Own The Underlying

Ermenegildo Zegna Group Reports FY 2025 Revenues1 of €1,917 Million, With an Improvement in Q4 Driven by DTC at the ZEGNA Brand

Lumen Completes Sale of Consumer Fiber-to-the-Home Business to AT&T

Fifth Third Announces Three New Members to its Board of Directors

Gold sell-off did not derail Deutsche Bank's bullish $6,000 target

Best Value Stocks to Buy for February 2nd

America's Best and Largest Network Just Got Larger: AT&T Completes Acquisition of Lumen's Mass Markets Fiber Business

EnviroGold Global to Commence Trading on the TSX Venture Exchange Effective February 4, 2026

XPLR Infrastructure, LP announces date for release of fourth-quarter and full-year 2025 financial results

Parsons Awarded $60 Million Contract To Design Claremont Extension Of Los Angeles's Metro A Line Light Rail System

Equinox Gold Announces Significant New AI-Supported Gold Discovery 8 km from Valentine Mill and Additional High-Grade Gold Mineralization Outside of Resources at The Valentine Gold Mine, Canada

Planet 13 Launches New Rewards Program, Offering Customers Up to 6x Points on Every Purchase

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

Jones Soda Announces Expanded Costco Program, Extending Record Q4 Momentum Into 2026

Apptopia Data Signals Material Improvement in Tinder Performance Heading into Match Group Earnings

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

Heineken Holding N.V. reports transactions under its current share buyback programme